Injections of corticosteroids and anesthetics guided by CT or MR imaging offer a reliable therapeutic option for the treatment of chronic lower back pain from sacroiliac joint lesions, according to researchers from Germany and the U.S.
Injections of corticosteroids and anesthetics guided by CT or MR imaging offer a reliable therapeutic option for the treatment of chronic lower back pain from sacroiliac joint lesions, according to researchers from Germany and the U.S.
Spondyloarthritis is a painful and debilitating type of rheumatoid arthritis of the spine. It hits particularly the sacroiliac joints, a primary source of lower back pain. Clinical diagnosis and treatment of the condition remain challenging, mostly because of the complexity of the sacroiliac joint anatomy. Cortisone injections can lessen sacroiliitis symptoms, but studies regarding their use and effectiveness are hard to come by.
Slow-release triamcinolone acetonide injections after CT-guided sacroiliac joint puncture can be an effective aid in the treatment of sacroiliitis, said principal investigator Dr. Kay-Geert Hermann, a radiologist from the Charité University of Medicine in Berlin.
Hermann and colleagues treated 47 patients with known unilateral or bilateral sacroiliitis who underwent 40-mg or 60-mg injections of the corticosteroid into the sacroiliac joint. The investigators evaluated patients' symptoms and adverse events daily during the first week and then at monthly intervals for a six-month follow-up period. They also split patients into two groups: In one, the puncture cannula was introduced in the joint; in the other, the cannula pierced a space outside the joint. An independent observer evaluated the images obtained at the end of the intervention.
Researchers found that only the intra-articular approach was reliable and successful.
Hermann attributed long-term treatment results to the adequate placement of the cannula and suggested a primary, though not exclusive, role for CT guidance.
In another study, researchers from Johns Hopkins and the Eberhard Karls University University of Tübingen proposed combining diagnosis and intervention in a one-stop shop approach to treat sacroiliitis. Principal investigator Dr. Jan Fritz and colleagues prospectively enrolled 42 patients who underwent a similar corticosteroid injection treatment, this time under gadolinium-enhanced real-time MR imaging with an open-bore 1.5T scanner.
They found the combined diagnostic and interventional approach feasible and cost-effective for the treatment of sacroiliac joint arthritis. Members of the audience, however, questioned the applicability of the technique in the U.S.
"Wait until next year," Fritz said.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
Surveillance Breast MRI Associated with Lower Risks of Advanced Second Breast Cancers
January 8th 2025After propensity score matching in a study of over 3,000 women with a personal history of breast cancer, researchers found that surveillance breast MRI facilitated a 59 percent lower risk in advanced presentations of second breast cancers.
Abbreviated MRI for Hepatocellular Carcinoma: What a New Meta-Analysis Reveals
January 6th 2025For hepatocellular carcinoma screening, a 19-study meta-analysis found the abbreviated MRI sequencing protocol of T2-weighted MRI, diffusion-weighted imaging (DWI) and hepatobiliary phase (HBP) imaging offered 88 percent sensitivity and 93 percent specificity.
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.